Cell-to-cell transmission of α-synuclein aggregates

Methods in Molecular Biology

Volumn 849, Issue , 2012, Pages 347-359

  Lee, Seung Jae ^a   Desplats, Paula ^b   Lee, He Jin ^c   Spencer, Brian ^b   Masliah, Eliezer ^d  

^a Konkuk University   (South Korea)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Konkuk University School of Medicine   (South Korea)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Synuclein; Lewy body disease; Neurodegeneration; Neurons; Parkinson's disease; Propagation; Protein dissemination

Indexed keywords

ALPHA SYNUCLEIN; LENTIVIRUS VECTOR;

ARTICLE; CELL COMMUNICATION; DIFFUSE LEWY BODY DISEASE; ENDOCYTOSIS; EXOCYTOSIS; HUMAN; LENTIVIRUS INFECTION; NERVE DEGENERATION; NEURAL STEM CELL; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; ANIMAL; CELL PROLIFERATION; CELL STRAIN HEK293; CENTRIFUGATION; CHEMISTRY; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; ISOLATION AND PURIFICATION; LENTIVIRINAE; MOUSE; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; PROTEIN SECONDARY STRUCTURE; PROTEIN TRANSPORT; STAINING;

ALPHA-SYNUCLEIN; ANIMALS; CELL COMMUNICATION; CELL PROLIFERATION; CENTRIFUGATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC VECTORS; HEK293 CELLS; HUMANS; LENTIVIRUS; MICE; NEURAL STEM CELLS; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN TRANSPORT; STAINING AND LABELING; TRANSFECTION;

EID: 84864629186     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-551-0_23     Document Type: Article

References (34)

1. Forman, M.S., Trojanowski, J.Q. and Lee, V.M. (2004). Neurodegenerative diseases: A decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 10 , 1055-63
2. Hanger, D.P. and Wray, S. (2010) Tau cleavage and tau aggregation in neurodegenerative disease. Biochem Soc Trans 38 , 1016-20
3. Hardy, J. (2006). Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal. J Alzheimers Dis 9 , 151-3
4. Selkoe, D.J. (1994). Normal and abnormal biology of the beta-amyloid precursor protein. Annu Rev Neurosci 17 , 489-517
5. Goedert, M. (2001). Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2 , 492-501
6. Goedert, M. (2001). Parkinson's disease and other alpha- synucleinopathies. Clin Chem Lab Med 39 , 308-12
7. Ross, C.A. (2004). Huntington's disease: new paths to pathogenesis. Cell 118 , 4-7
8. Walsh, D.M., Klyubin, I., Fadeeva, J.V., Rowan, M.J. and Selkoe, D.J. (2002). Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem Soc Trans 30 , 552-7
9. Walsh, D.M. and Selkoe, D.J. (2004). Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. Protein Pept Lett 11 , 213-28
10. Walsh, D.M. and Selkoe, D.J. (2007). A beta oligomers-A decade of discovery. J Neurochem 101 , 1172-84
11. El-Agnaf, O.M., Walsh, D.M. and Allsop, D. (2003). Soluble oligomers for the diagnosis of neurodegenerative diseases. Lancet Neurol 2 , 461-2
12. Alvarez-Erviti, L., Rodriguez-Oroz, M.C., Cooper, J.M., Caballero, C., Ferrer, I., Obeso, J.A. and Schapira, A.H. (2010). Chaperonemediated autophagy markers in Parkinson disease brains. Arch Neurol 67 , 1464-72
13. Cherra, S.J., 3 rd, Dagda, R.K. and Chu, C.T. (2010). Review: autophagy and neurodegeneration: survival at a cost? Neuropathol Appl Neurobiol 36 , 125-32
14. Crews, L. et al. (2010). Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alphasynucleinopathy. PLoS One 5, e9313
15. Cuervo, A.M., Wong, E.S. and Martinez-Vicente, M. (2010). Protein degradation, aggregation, and misfolding. Mov Disord 25 Suppl 1 , S49-54
16. Luo, G.R. and Le, W.D. (2010). Collective roles of molecular chaperones in protein degradation pathways associated with neurodegenerative diseases. Curr Pharm Biotechnol 11 , 180-7
17. Matsuda, N. and Tanaka, K. (2010). Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease? J Alzheimers Dis 19 , 1-9
18. Aguzzi, A., Sigurdson, C. and Heikenwaelder, M. (2008). Molecular mechanisms of prion pathogenesis. Annu Rev Pathol 3 , 11-40
19. Caughey, B., Baron, G.S., Chesebro, B. and Jeffrey, M. (2009). Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu Rev Biochem 78 , 177-204
20. Desplats, P. et al. (2009). Inclusion formation and neuronal cell death through neuron-toneuron transmission of alpha-synuclein. Proc Natl Acad Sci USA 106 , 13010-5
21. Kordower, J.H., Chu, Y., Hauser, R.A., Freeman, T.B. and Olanow, C.W. (2008). Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 14 , 504-6
22. Lee, H.J., Suk, J.E., Bae, E.J. and Lee, S.J. (2008). Clearance and deposition of extracellular alpha-synuclein aggregates in microglia. Biochem Biophys Res Commun 372 , 423-8
23. Lee, S.J. (2008). Origins and effects of extracellular alpha-synuclein: implications in Parkinson's disease. J Mol Neurosci 34 , 17-22
24. Lee, S.J., Desplats, P., Sigurdson, C., Tsigelny, I. and Masliah, E. (2010). Cell-to-cell transmission of non-prion protein aggregates. Nat Rev Neurol 6 , 702-6
25. Davidson, W.S., Jonas, A., Clayton, D.F. and George, J.M. (1998). Stabilization of alphasynuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273 , 9443-9
26. Iwai, A. (2000). Properties of NACP/alphasynuclein and its role in Alzheimer's disease. Biochim. Biophys. Acta 1502 , 95-109
27. Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., de Silva, H.A., Kittel, A. and Saitoh, T. (1995). The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14 , 467-75
28. Weinreb, P.H., Zhen, W., Poon, A.W., Conway, K.A. and Lansbury, P.T., Jr. (1996). NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35 , 13709-15
29. Tsigelny, I.F. et al. (2008). Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases. PLoS One 3 , e3135
30. Schiesling, C., Kieper, N., Seidel, K. and Kruger, R. (2008). Review: Familial Parkinson's disease-genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease. Neuropathol Appl Neurobiol 34 , 255-71
31. McKeith, I.G. (2006). Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis 9 , 417-23
32. McKeith, I.G. et al. (2005). Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65 , 1863-72
33. Lee, H.J., Patel, S. and Lee, S.J. (2005). Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci 25 , 6016-24
34. Lee, H.J. et al. (2010). Direct transfer of alphasynuclein from neuron to astroglia causes infl ammatory responses in synucleinopathies. J Biol Chem 285 , 9262-72.